Literature DB >> 23975191

TNF-α haplotype association with polycystic ovary syndrome - a South Indian study.

M L N Deepika1, K Ranjith Reddy, A Yashwanth, V Usha Rani, K Prasanna Latha, Parveen Jahan.   

Abstract

BACKGROUND: Tumor Necrosis Factor Alpha (TNF-α), is a proinflammatory cytokine in the pathogenesis of Polycystic Ovary Syndrome (PCOS). In order to investigate the role of rs1800629 and rs1799964 polymorphisms in relation to anthropometric measures, family history of complex diseases, diet and clinical features, we performed a case control study in PCOS women from South India.
METHODS: A total of 589 samples comprising of 283 patients and 306 controls were enrolled in the present study. Patients were selected based on Rotterdam criteria and ultrasound scanned normal women were selected as controls. Following extraction of DNA, genotyping for rs1800629 and rs1799964 was performed by polymerase chain reaction using tetra primers and PCR-RFLP respectively.
RESULTS: The distribution of genotypes for rs1799964 was significantly different between the groups (p = 0.001), however it was not for rs1800629. Haplotype analysis revealed a significant difference between patients and controls. The predisposing and protective role of haplotype with mutant allele at both loci (combination 3) and haplotype with mutant allele at either loci was reflected by the over representation of combination 3 in patients and combination 2 in controls respectively. In addition, rs1799964 showed an association with dietary habit, clinical hyperandrogenism and AAO. The modifying role of TT genotype on age at onset was noted in quartile analysis.
CONCLUSION: Replicative studies on the influence of TNF-α polymorphism in different ethnic groups may identify the potentiality of these polymorphisms as markers of inflammation and in turn may help the clinicians for the better management of the condition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975191      PMCID: PMC3879940          DOI: 10.1007/s10815-013-0080-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  35 in total

1.  The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II.

Authors:  V Nicaud; S Raoux; O Poirier; F Cambien; D St J O'Reilly; L Tiret
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

2.  Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

Authors:  B Zhang; J Berger; E Hu; D Szalkowski; S White-Carrington; B M Spiegelman; D E Moller
Journal:  Mol Endocrinol       Date:  1996-11

3.  Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum.

Authors:  M Brännström; B E Fridén; M Jasper; R J Norman
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-04       Impact factor: 2.435

4.  No association between the -308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries.

Authors:  C R Milner; J E Craig; N D Hussey; R J Norman
Journal:  Mol Hum Reprod       Date:  1999-01       Impact factor: 4.025

Review 5.  Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

Authors:  D H Abbott; D K Barnett; C M Bruns; D A Dumesic
Journal:  Hum Reprod Update       Date:  2005 Jul-Aug       Impact factor: 15.610

6.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

Authors:  Jaime Uribarri; Melpomeni Peppa; Weijing Cai; Teresia Goldberg; Min Lu; Cijiang He; Helen Vlassara
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

7.  Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus.

Authors:  Masahiko Furuta; Yutaka Yano; Kuninobu Ito; E C Gabazza; Akira Katsuki; Takashi Tanaka; Kouhei Ohtake; Naoki Hirata; Yasuko Hori; Rika Araki-Sasaki; Yasuhiro Sumida; Yukihiko Adachi
Journal:  Diabetes Res Clin Pract       Date:  2002-05       Impact factor: 5.602

8.  Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory.

Authors:  Hong Ruan; Nir Hacohen; Todd R Golub; Luk Van Parijs; Harvey F Lodish
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

9.  Association of TNF-alpha gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study.

Authors:  Yi-Chun Chen; Fen-Ju Hu; Phoebe Chen; Yih-Ru Wu; Hsiu-Chuan Wu; Sien-Tsong Chen; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  BMC Neurol       Date:  2010-06-10       Impact factor: 2.474

10.  Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia.

Authors:  G Chen; S H Wang; H Z Zheng; J J Walker; J H McKillop
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

View more
  9 in total

1.  CYP11A1 microsatellite (tttta)n polymorphism in PCOS women from South India.

Authors:  K Ranjith Reddy; M L N Deepika; K Supriya; K Prasanna Latha; S S Lakshmana Rao; V Usha Rani; P Jahan
Journal:  J Assist Reprod Genet       Date:  2014-05-04       Impact factor: 3.412

Review 2.  Associations between TNF-α and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis.

Authors:  Haijing Wu; Ke Yu; Zhenghui Yang
Journal:  J Assist Reprod Genet       Date:  2015-02-18       Impact factor: 3.412

Review 3.  Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.

Authors:  Giorgia Scarfò; Simona Daniele; Jonathan Fusi; Marco Gesi; Claudia Martini; Ferdinando Franzoni; Vito Cela; Paolo Giovanni Artini
Journal:  Biomedicines       Date:  2022-06-02

4.  Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.

Authors:  Suk Pyo Shin; Nam Keun Kim; Ju Hwan Kim; Ju Ho Lee; Jung Oh Kim; Sung Hwan Cho; Hana Park; Mi Na Kim; Kyu Sung Rim; Seong Gyu Hwang
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

5.  Association of TNF-alpha, IL-6 and IL-1beta gene polymorphisms with polycystic ovary syndrome: a meta-analysis.

Authors:  Renyong Guo; Ying Zheng; Jiezuan Yang; Nengneng Zheng
Journal:  BMC Genet       Date:  2015-01-30       Impact factor: 2.797

6.  Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.

Authors:  Fahimeh Kordestani; Sahar Mazloomi; Yousef Mortazavi; Saeideh Mazloomzadeh; Mojtaba Fathi; Haleh Rahmanpour; Abolfazl Nazarian
Journal:  BMC Med Genet       Date:  2018-08-22       Impact factor: 2.103

7.  Association of IL-1β, IL-6, TNF-α, and TGFβ1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome.

Authors:  Afrah F Alkhuriji; Suliman Y Al Omar; Zainb A Babay; Manal F El-Khadragy; Lamjed A Mansour; Wazirah G Alharbi; Mahmoud I Khalil
Journal:  Dis Markers       Date:  2020-05-05       Impact factor: 3.434

Review 8.  Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India.

Authors:  Mohammad Ashraf Ganie; Vishnu Vasudevan; Imtiyaz Ahmad Wani; Mohammad Salem Baba; Tasleem Arif; Aafia Rashid
Journal:  Indian J Med Res       Date:  2019-10       Impact factor: 2.375

Review 9.  In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond.

Authors:  Agata Wawrzkiewicz-Jałowiecka; Karolina Kowalczyk; Paulina Trybek; Tomasz Jarosz; Patrycja Radosz; Marcin Setlak; Paweł Madej
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.